Headquartered in Lewisville, TX, the company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Our products are distributed in more than 70 countries around the world via Orthofix sales representatives, distributors and subsidiaries.
Founded in Verona, Italy in 1980, Orthofix has approximately 900 employees around the world who are dedicated to the development, manufacturing and distribution of orthopedic and spine products and regenerative tissue forms. Many of our innovative product offerings were cultivated through affiliations with surgeons and premiere health care organizations. Orthofix is proud to collaborate on research and development activities with leading clinical organizations such as the Musculoskeletal Transplant Foundation (MTF) and the Texas Scottish Rite Hospital for Children.
Type | Public | |
Founded | 1980 | |
HQ | Z.a.i., IT | Map |
Website | orthofix.com | |
Employee Ratings | More | |
Overall Culture | A+ | More |
USD | |
---|---|
Revenue (Q3, 2020) | 111.0m |
Gross profit (Q3, 2020) | 84.7m |
Gross profit margin (Q3, 2020), % | 76.4% |
Net income (Q3, 2020) | 4.7m |
EBIT (Q3, 2020) | 4.2m |
Market capitalization (8-Jan-2021) | 843.1m |
Closing stock price (8-Jan-2021) | 43.6 |
Cash (30-Sept-2020) | 79.8m |
EV | 785.8m |
USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 579.0m | 447.6m | 400.5m | 402.3m | 396.5m | 409.8m | 433.8m | 453.0m | 460.0m |
Cost of goods sold | 139.2m | 98.3m | 102.3m | 98.9m | 86.5m | 87.9m | 93.0m | 96.6m | 100.6m |
Gross profit | 439.8m | 349.3m | 298.2m | 303.4m | 310.0m | 321.9m | 340.8m | 356.4m | 359.3m |
Gross profit Margin, % | 76% | 78% | 74% | 75% | 78% | 79% | 79% | 79% | 78% |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 143.6m | 144.7m | 143.1m | 119.5m | 114.8m | 103.4m | 98.3m | 92.7m | 101.3m | 101.0m | 101.0m | 89.8m | 101.0m | 101.2m | 98.7m | 104.1m | 98.5m | 102.7m | 108.9m | 105.2m | 108.7m | 111.5m | 111.7m | 109.1m | 115.9m | 113.5m | 104.8m | 73.1m | 111.0m |
Cost of goods sold | 34.7m | 36.0m | 32.9m | 23.7m | 22.4m | 25.6m | 20.2m | 23.9m | 22.6m | 25.4m | 25.3m | 19.3m | 21.9m | 23.9m | 22.1m | 22.5m | 19.9m | 22.6m | 23.2m | 23.7m | 24.1m | 22.8m | 24.0m | 23.7m | 25.8m | 24.9m | 23.4m | 23.2m | 26.2m |
Gross profit | 108.9m | 108.7m | 110.3m | 95.8m | 92.4m | 77.8m | 78.0m | 68.8m | 78.7m | 75.6m | 75.7m | 70.4m | 79.0m | 77.3m | 76.5m | 81.6m | 78.6m | 80.2m | 85.8m | 81.5m | 84.6m | 88.7m | 87.7m | 85.4m | 90.0m | 88.6m | 81.4m | 50.0m | 84.7m |
Gross profit Margin, % | 76% | 75% | 77% | 80% | 81% | 75% | 79% | 74% | 78% | 75% | 75% | 78% | 78% | 76% | 78% | 78% | 80% | 78% | 79% | 77% | 78% | 80% | 78% | 78% | 78% | 78% | 78% | 68% | 76% |
USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|
Cash | 33.2m | 31.1m | 30.5m | 36.8m | 63.7m | 39.6m | 81.2m | 69.6m | 69.7m |
Accounts Receivable | 146.5m | 107.3m | 75.6m | 61.4m | 59.8m | 2.8m | 63.4m | 77.7m | 86.8m |
Prepaid Expenses | 28.1m | 34.1m | 25.9m | 26.6m | 31.2m | 25.9m | 17.9m | 20.9m | |
Inventories | 91.2m | 83.4m | 90.6m | 59.8m | 57.6m | 63.3m | 81.3m | 76.8m | 82.4m |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 27.5m | 29.0m | 47.1m | 50.1m | 53.6m | 33.7m | 27.4m | 22.2m | 26.7m | 28.9m | 29.8m | 29.8m | 55.9m | 63.7m | 39.8m | 40.5m | 46.8m | 41.7m | 44.3m | 53.9m | 77.1m | 45.7m | 53.8m | 46.7m | 52.1m | 56.8m | 57.7m | 172.9m | 79.8m |
Accounts Receivable | 139.2m | 142.2m | 156.5m | 149.5m | 156.0m | 96.5m | 90.8m | 75.3m | 76.9m | 63.3m | 62.5m | 58.5m | 58.4m | 56.2m | 55.3m | 56.4m | 52.9m | 59.4m | 61.2m | 61.2m | 77.2m | 74.4m | 74.4m | 79.6m | 80.6m | 79.7m | 77.8m | 67.4m | 73.1m |
Prepaid Expenses | 20.8m | 21.7m | 21.9m | 25.4m | 28.1m | 34.4m | 29.0m | 27.3m | 28.8m | 43.9m | 39.3m | 25.8m | 24.7m | 31.9m | 19.1m | 19.7m | 20.5m | 19.5m | 17.2m | 18.2m | 31.2m | 35.6m | 34.5m | 16.4m | 21.0m | 19.6m | 21.2m | 20.7m | 18.5m |
Inventories | 98.0m | 94.7m | 90.9m | 78.4m | 80.8m | 84.7m | 94.9m | 100.2m | 92.8m | 70.9m | 64.3m | 56.7m | 59.2m | 57.8m | 59.8m | 61.3m | 65.0m | 66.3m | 75.9m | 80.1m | 77.7m | 81.7m | 79.9m | 79.1m | 79.1m | 81.0m | 82.7m | 82.0m | 82.9m |
USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|
Net Income | (1.1m) | 42.8m | (25.5m) | (8.5m) | (2.8m) | 3.1m | 6.2m | 13.8m | (28.5m) |
Depreciation and Amortization | 22.8m | 20.6m | 22.7m | 22.9m | 20.9m | 20.8m | 20.1m | 18.7m | 24.7m |
Inventories | (13.8m) | (2.5m) | (6.6m) | 8.1m | 3.1m | (5.3m) | (15.6m) | 9.7m | (5.7m) |
Accounts Payable | 576.0k | 4.6m | (2.3m) | (6.5m) | 3.0m | (1.8m) | 2.3m | (170.0k) | 2.1m |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (25.8m) | (13.5m) | 12.0m | 23.2m | 30.8m | 4.5m | 2.2m | (17.6m) | (782.0k) | (3.2m) | (2.7m) | (2.7m) | 1.2m | 4.7m | 5.2m | 6.2m | 4.9m | 897.0k | 350.0k | (40.1m) | 25.7m | 7.2m | 11.9m | ||||||
Depreciation and Amortization | 11.3m | 17.3m | 5.7m | 11.0m | 15.5m | 5.0m | 10.2m | 15.5m | 6.0m | 11.5m | 17.1m | 5.1m | 10.4m | 15.4m | 4.4m | 8.9m | 13.7m | 5.7m | 11.9m | 18.2m | 6.3m | 13.3m | 22.3m | ||||||
Inventories | (12.4m) | (14.5m) | 732.0k | 2.2m | (959.0k) | (2.1m) | (12.9m) | (11.6m) | (1.7m) | 2.2m | 5.5m | (2.7m) | (11.1m) | (14.7m) | 1.7m | 5.3m | 6.9m | (2.5m) | (2.4m) | (5.0m) | (848.0k) | 468.0k | 246.0k | ||||||
Accounts Payable | (2.3m) | (2.2m) | (3.1m) | (4.4m) | 2.1m | (7.2m) | (3.5m) | (8.0m) | (6.7m) | (5.0m) | (6.8m) | 1.0m | (950.0k) | (2.2m) | (4.5m) | (3.8m) | (2.8m) | 1.9m | 1.6m | 447.0k | 28.0k | (4.8m) | (3.1m) |
USD | Q2, 2011 |
---|---|
Financial Leverage | 2.2 x |
A+
91/100
A+
90/100
A+
100/100
When was Orthofix founded?
Orthofix was founded in 1980.
Who are Orthofix key executives?
Orthofix's key executives are Ronald Matricaria, Maria Sainz and James Hinrichs.
How many employees does Orthofix have?
Orthofix has 1,055 employees.
What is Orthofix revenue?
Latest Orthofix annual revenue is $460 m.
What is Orthofix revenue per employee?
Latest Orthofix revenue per employee is $436 k.
Who are Orthofix competitors?
Competitors of Orthofix include Mammotome, Zimmer Biomet and NuVasive.
Where is Orthofix headquarters?
Orthofix headquarters is located at 9 Via delle Nazioni, Z.a.i..
Where are Orthofix offices?
Orthofix has offices in Z.a.i., Sona, Lewisville, Sunnyvale and in 7 other locations.
How many offices does Orthofix have?
Orthofix has 11 offices.
Receive alerts for 300+ data fields across thousands of companies